| Subject: | FDA issues Statement on JAMA Article on Automated External Defibrillators |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Mon, 21 Aug 2006 - 12:00 am |
| The FDA has issued a statement listing points in a recent article about automated external defibrillators (AEDs) in the Journal of the American Medical Association on which the agency disagrees.
According to the FDA, the JAMA article, titled Recalls and Safety Alerts Affecting Automated External Defibrillators helps inform the public about the safety of AEDs. The FDA supports this kind of research and most of the conclusions reached in the JAMA article are consistent with FDA's own findings.... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
REFERENCE:
External Links:
|
|
StayAlert!® Virtual Compliance Administrator™ keeps clients informed by email of any changes to Federal regulations, including Joint Commission (TJC, formerly JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG, and many more, and also provides downloadable tools to ensure compliance. StayAlert! is a premium product sold as an annual site-license subscription. With the site license, the client can sign up an unlimited number of users for the email alerts and access to the StayAlert! online regulatory library. The strength of StayAlert! rests in its ability to allow healthcare organizations to streamline their businesses using the Internet as a foundation architecture. StayAlert! provides cost containment and reduction through elimination of unnecessary overhead, and work caused by errors or poor access to information. |
|
